Authors


Ann Curoe, MD, MPH

Latest:

The Role of Nurse Practitioners in Primary Healthcare

The potential of nurse practitioners is not being fully realized in primary care medical practices. Consequently, cost and quality gains are not being achieved.


Kate Andrade, MPH

Latest:

Clinical Characteristics and Treatment Patterns Among US Patients With HIV

It is important to take into account individual complexities such as comorbidities and pill burden when selecting antiretroviral therapy regimens for individuals living with HIV.



David J. Meyers, MPH

Latest:

Medicare Advantage Plan Representatives’ Perspectives on Pay for Success

This study examined how Medicare Advantage plan representatives perceive the alternative financing model Pay for Success and its potential to address members’ social risk factors.


A. Gabriela Rosales, MS

Latest:

Do Patient or Provider Characteristics Impact Management of Diabetes?

Many more patient than provider characteristics are associated with optimal or poor glycemic control and treatment intensification when glycemic control is initially lost.


Meredith B. Rosenthal, PhD

Latest:

ACOs With Risk-Bearing Experience Are Likely Taking Steps to Reduce Low-Value Medical Services

Experience with risk-based contracting best predicts active engagement of accountable care organizations in reducing low-value medical services, mainly through physician education and encouraging shared decision making.


Ryan Bitton, PharmD, MBA

Latest:

Key Takeaways for the Management of HIV PrEP

A panel of experts share closing thoughts and advice for the management and uptake of HIV PrEP therapy.


Julie Sanderson-Austin, RN

Latest:

Role of Pharmaceuticals in Value-Based Healthcare: A Framework for Success

A framework for the role of pharmaceuticals in value-based healthcare, practical examples from organizations that have made the transition, and implementation considerations.





Richard J. Brand, PhD

Latest:

Bridging the Digital Divide: Mobile Access to Personal Health Records Among Patients With Diabetes

Racial/ethnic minorities and patients living in poorer neighborhoods were more likely to access their personal health record exclusively with a mobile device.






John Min, BS

Latest:

Real-World Economic Value of a 21-Gene Assay in Early-Stage Breast Cancer

Universal gene expression profiling of patients with stage II breast cancer resulted in outpatient savings of $11,000 (inclusive of testing costs) within 6 months of initiation of medical therapy.


Richard Adule

Latest:

Enhanced Care Coordination Improves HIV Viral Load Suppression Rates

Enhanced care coordination in New York City that leveraged surveillance data with a health plan’s Medicaid managed care roster improved its HIV viral load suppression rate.


Lesley F. Degner, RN, PhD

Latest:

Preferred Roles in Treatment Decision Making Among Patients With Cancer: A Pooled Analysis of Studies Using the Control Preferences Scale

This pooled analysis assesses preferred roles in treatment decision making, actual roles, and preferred versus actual discordance among 6 studies of patients with cancer.


Stephen J. Kovach III, MD

Latest:

LACE+ Index as a Predictor of 90-Day Plastic Surgery Outcomes

Patients with higher LACE+ index scores have significantly greater risk of unplanned readmission, emergency department visits, and reoperation after plastic surgery.



Mark H. Ebell, MD, MS

Latest:

Antibiotic Use for Viral Acute Respiratory Tract Infections Remains Common

Antibiotic use for acute respiratory tract infections that are largely viral remains common. Macrolide use has increased since 2007, and 9% of patients received a second antibiotic within 30 days.


Lindsey Herrel, MD

Latest:

Implications of Evolving Delivery System Reforms for Prostate Cancer Care

Healthcare integration was associated with small declines in treatment, but no change in overtreatment of prostate cancer. Integrated care delivery alone may be insufficient to curtail overtreatment.




Michael Bogart, PharmD

Latest:

Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT

This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.



the PLoS Medicine Editors*

Latest:

Comparative Effectiveness Research: Challenges for Medical Journals

In order to encourage dissemination, this commentary is freely available in PLoS Medicine, and will also be published in Medical Decision Making, Croatian Medical Journal, The Cochrane Library, Trials, and Journal of Clinical Epidemiology.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo